SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 380.00 |
| Enterprise Value ($M) | 387.65 |
| Book Value ($M) | 3.76 |
| Book Value / Share | 0.10 |
| Price / Book | 100.99 |
| NCAV ($M) | -7.66 |
| NCAV / Share | -0.21 |
| Price / NCAV | -49.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.60 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.90 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.36 |
| Current Ratio | 0.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.11 |
| Assets | 17.53 |
| Liabilities | 13.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Novogratz Michael | 5.86 | ||
| 13G | GSR Growth Investments LP | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 121,108 | 352,308 | 34.38 | |
| 36,533 | 110,524 | 33.05 | |
| 62,607 | 164,992 | 37.95 | |
| 61,725 | 331,140 | 18.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TTNP – Titan Pharmaceuticals, Inc. | UNCY – Unicycive Therapeutics, Inc. |
| UPC – Universe Pharmaceuticals INC | VERU – Veru Inc. |
| VIVS – VivoSim Labs, Inc. |
Financial data and stock pages provided by
Fintel.io